The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis
Abstract
Various sensors that detect double-stranded RNA, presumably of viral origin, exist in eukaryotic cells and induce IFN-responses. Ongoing IFN-responses have also been documented in a variety of human autoimmune diseases including relapsing-remitting multiple sclerosis (RRMS) but their origins remain obscure. We find increased IFN-responses in leukocytes in relapsing-remitting multiple sclerosis at distinct stages of disease. Moreover, endogenous RNAs isolated from blood cells of these same patients recapitulate this IFN-response if transfected into naïve cells. These endogenous RNAs are double-stranded RNAs, contain Alu and Line elements and are transcribed from leukocyte transcriptional enhancers. Thus, transcribed endogenous retrotransposon elements can co-opt pattern recognition sensors to induce IFN-responses in RRMS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alu- and LINE-derived dsRNA initiate innate immune responses in models of Aicardi-Goutières syndrome (AGS) (10) and multiple sclerosis (14, 37).”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [37]
In the citing paper
“On the basis of mechanistic links between dsRNA and the innate immune response in other human disorders (36, 37), we next determined whether dsRNA formation is a causal factor driving neuroinflammation.”
From Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Enhancers as non-coding RNA transcription units: recent insights and future perspectives
Li, W., Notani, D., & Rosenfeld, M. G. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.4 · Cited by 710
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
Tarallo, V., Hirano, Y., Gelfand, B. D., Dridi, S., Kerur, N., Kim, Y., Cho, W. G., Kaneko, H., Fowler, B. J., Bogdanovich, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.036 · Cited by 592
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates
Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., et al. (2014) · Nature · doi:10.1038/nature13590 · Cited by 557
Mechanisms of inflammasome activation: recent advances and novel insights
Vanaja, S. K., Rathinam, V. A. K., & Fitzgerald, K. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.009 · Cited by 499
Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation
Ahmad, S., Mu, X., Yang, F., Greenwald, E., Park, J. W., Jacob, E., Zhang, C.-Z., & Hur, S. (2018) · Cell · doi:10.1016/j.cell.2017.12.016 · Cited by 449 · cited 2×
“For example, studies suggest that the normal RNA-rich environment in cells may actually inhibit activation of the dsRNA sensor, MDA5, and perhaps additional dsRNA sensors by Alu and LINE dsRNAs, thus limiting activation of IFN responses creating a kind of state of innate immune tolerance [32].”
Background
Research works printed but not linked: 63
- Medzhitov, 2001, Toll-like receptors and innate immunity, Nat. Rev. Immunol., 1, 135, 10.1038/35100529 · DOI · Paper page
- Medzhitov, 2000, Innate immune recognition: mechanisms and pathways, Immunol. Rev., 173, 89, 10.1034/j.1600-065X.2000.917309.x · DOI · Paper page
- Janeway, 2002, Innate immune recognition, Annu. Rev. Immunol., 20, 197, 10.1146/annurev.immunol.20.083001.084359 · DOI · Paper page
- Medzhitov, 1998, Innate immune recognition and control of adaptive immune responses, Semin, Immunology, 10, 351
- Der, 1998, Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays, Proc. Natl. Acad. Sci. U. S. A, 95, 15623, 10.1073/pnas.95.26.15623 · DOI · Paper page
- Kalvakolanu, 1996, An overview of the interferon system: signal transduction and mechanisms of action, Canc. Invest., 14, 25, 10.3109/07357909609018435 · DOI
- Pestka, 2004, Interferons, interferon-like cytokines, and their receptors, Immunol. Rev., 202, 8, 10.1111/j.0105-2896.2004.00204.x · DOI · Paper page
- Biron, 2001, Interferons alpha and beta as immune regulators - a new look, Immunity, 14, 661, 10.1016/S1074-7613(01)00154-6 · DOI · Paper page
- Samuel, 2001, Antiviral actions of interferons, Clin. Microbiol. Rev., 14, 778, 10.1128/CMR.14.4.778-809.2001 · DOI · Paper page
- Trinchieri, 2010, Type I interferon: friend or foe?, J. Exp. Med., 207, 2053, 10.1084/jem.20101664 · DOI · Paper page
- Schoggins, 2011, A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, 472, 481, 10.1038/nature09907 · DOI · Paper page
- Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 · DOI · Paper page
- Bennett, 2003, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J. Exp. Med., 197, 711, 10.1084/jem.20021553 · DOI · Paper page
- Baechler, 2003, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc. Natl. Acad. Sci. U. S. A, 100, 10.1073/pnas.0337679100 · DOI · Paper page
- Lubbers, 2013, The type I IFN signature as a biomarker of preclinical rheumatoid arthritis, Ann. Rheum. Dis., 72, 776, 10.1136/annrheumdis-2012-202753 · DOI · Paper page
- Verweij, 2013, Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy, Discov. Med., 15, 51
- Crow, 2014, Type I interferon in the pathogenesis of lupus, J. Immunol., 192, 5459, 10.4049/jimmunol.1002795 · DOI · Paper page
- Sharma, 2015, Nucleic acid-sensing receptors: rheostats of autoimmunity and autoinflammation, J. Immunol., 195, 3507, 10.4049/jimmunol.1500964 · DOI
- Jimenez-Dalmaroni, 2016, The critical role of toll-like receptors - from microbial recognition to autoimmunity: a comprehensive review, Autoimmun. Rev., 15, 1, 10.1016/j.autrev.2015.08.009 · DOI · Paper page
- Nezos, 2015, Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis, J. Autoimmun., 63, 47, 10.1016/j.jaut.2015.07.002 · DOI · Paper page
- Ranoa, 2016, Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs, Oncotarget, 7, 26496, 10.18632/oncotarget.8420 · DOI · Paper page
- Belair, 2018, Noncoding RNA surveillance: the ends justify the means, Chem. Rev., 118, 4422, 10.1021/acs.chemrev.7b00462 · DOI
- Portal, 2015, Human cells contain natural double-stranded RNAs with potential regulatory functions, Nat. Struct. Mol. Biol., 22, 89, 10.1038/nsmb.2934 · DOI
- Hung, 2015, The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression, Science, 350, 455, 10.1126/science.aac7442 · DOI · Paper page
- Houseley, 2009, The many pathways of RNA degradation, Cell, 136, 763, 10.1016/j.cell.2009.01.019 · DOI · Paper page
- Mighell, 1997, Alu sequences, FEBS Lett., 417, 1, 10.1016/S0014-5793(97)01259-3 · DOI
- Deininger, 2011, Alu elements: know the SINEs, Genome Biol., 12, 236, 10.1186/gb-2011-12-12-236 · DOI · Paper page
- Marullo, 2010, Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data, Genome Biol., 11, R9, 10.1186/gb-2010-11-1-r9 · DOI
- Spurlock, 2015, Defective structural RNA processing in relapsing-remitting multiple sclerosis, Genome Biol., 16, 58, 10.1186/s13059-015-0629-x · DOI
- Tossberg, 2012, Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis, Genes Immun., 13, 146, 10.1038/gene.2011.66 · DOI
- Tossberg, 2013, Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis, J. Clin. Bioinf., 3, 18, 10.1186/2043-9113-3-18 · DOI
- Spurlock, 2017, Profiles of long noncoding RNAs in human naive and memory T cells, J. Immunol., 199, 547, 10.4049/jimmunol.1700232 · DOI
- Spurlock, 2015, Expression and functions of long noncoding RNAs during human T helper cell differentiation, Nat. Commun., 6, 6932, 10.1038/ncomms7932 · DOI · Paper page
- Soutto, 2002, Cutting edge: distal regulatory elements are required to achieve selective expression of IFN-gamma in Th1/Tc1 effector cells, J. Immunol., 169, 6664, 10.4049/jimmunol.169.12.6664 · DOI
- Schonborn, 1991, Monoclonal-antibodies to double-stranded-RNA as probes of RNA structure in crude nucleic-acid extracts, Nucleic Acids Res., 19, 2993, 10.1093/nar/19.11.2993 · DOI · Paper page
- Bolger, 2014, Trimmomatic: a flexible trimmer for Illumina sequence data, Bioinformatics, 30, 2114, 10.1093/bioinformatics/btu170 · DOI · Paper page
- Li, 2011, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinf., 12, 323, 10.1186/1471-2105-12-323 · DOI · Paper page
- Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
- Jurka, 2000, Repbase Update - a database and an electronic journal of repetitive elements, Trends Genet., 16, 418, 10.1016/S0168-9525(00)02093-X · DOI · Paper page
- Aune, 2017, Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants, J. Autoimmun., 81, 99, 10.1016/j.jaut.2017.03.014 · DOI
- Wang, 2013, VirusFinder: software for efficient and accurate detection of viruses and their integration sites in host genomes through next generation sequencing data, PLoS One, 8, e64465, 10.1371/journal.pone.0064465 · DOI · Paper page
- Robinson, 2011, Integrative genomics viewer, Nat. Biotechnol., 29, 24, 10.1038/nbt.1754 · DOI · Paper page
- Hnisz, 2013, Super-enhancers in the control of cell identity and disease, Cell, 155, 934, 10.1016/j.cell.2013.09.053 · DOI · Paper page
- Natoli, 2012, Noncoding transcription at enhancers: general principles and functional models, Annu. Rev. Genet., 46, 1, 10.1146/annurev-genet-110711-155459 · DOI · Paper page
- Pott, 2015, What are super-enhancers?, Nat. Genet., 47, 8, 10.1038/ng.3167 · DOI · Paper page
- Vahedi, 2015, Super-enhancers delineate disease-associated regulatory nodes in T cells, Nature, 520, 558, 10.1038/nature14154 · DOI · Paper page
- Liu, 1995, Cell stress and translational inhibitors transiently increase the abundance of mammalian Sine transcripts, Nucleic Acids Res., 23, 1758, 10.1093/nar/23.10.1758 · DOI · Paper page
- Stein, 2005, Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity, Cell, 121, 529, 10.1016/j.cell.2005.03.009 · DOI · Paper page
- Wolin, 2002, The LA protein, Annu. Rev. Biochem., 71, 375, 10.1146/annurev.biochem.71.090501.150003 · DOI · Paper page
- Porath, 2017, Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance, Genome Biol., 18, 185, 10.1186/s13059-017-1315-y · DOI · Paper page
- Bonaci-Nikolic, 2009, Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis, Lupus, 18, 78, 10.1177/0961203308093550 · DOI
- Crispin, 2005, Systemic lupus erythematosus induced by therapy with interferon-beta in a patient with multiple sclerosis, Lupus, 14, 495
- Nortvedt, 1999, Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a, Mult. Scler., 5, 317, 10.1177/135245859900500503 · DOI
- Polman, 1995, The treatment of multiple-sclerosis - current and Future, Curr. Opin. Neurol., 8, 200, 10.1097/00019052-199506000-00008 · doi:10.1097/00019052-199506000-00008
- Goodkin, 1994, Interferon beta-1b, Lancet, 344, 1702, 10.1016/S0140-6736(94)90484-7 · doi:10.1016/s0140-6736(94)90484-7
- Myhr, 1999, Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis, Neurology, 52, 1049, 10.1212/WNL.52.5.1049 · DOI
- Panitch, 1987, Treatment of Multiple-Sclerosis with Gamma-interferon - exacerbations associated with activation of the immune-system, Neurology, 37, 1097, 10.1212/WNL.37.7.1097 · DOI · Paper page
- Arellano, 2017, Th1 and Th17 cells and associated cytokines discriminate among clinically isolated syndrome and multiple sclerosis phenotypes, Front. Immunol., 8, 753, 10.3389/fimmu.2017.00753 · DOI
- Su, 2014, Evolution of Alu elements toward enhancers, Cell Rep., 7, 376, 10.1016/j.celrep.2014.03.011 · DOI
- Guarda, 2011, Type I interferon inhibits interleukin-1 production and inflammasome activation, Immunity, 34, 213, 10.1016/j.immuni.2011.02.006 · DOI · Paper page
- Billiau, 2006, Anti-inflammatory properties of Type I interferons, Antivir. Res., 71, 108, 10.1016/j.antiviral.2006.03.006 · DOI
- Theofilopoulos, 2005, Type I interferons (alpha/beta) in immunity and autoimmunity, Annu. Rev. Immunol., 23, 307, 10.1146/annurev.immunol.23.021704.115843 · DOI · Paper page
- Aune, 1982, Activation of a suppressor T-cell pathway by interferon, Proc. Natl. Acad. Sci. U. S. A, 79, 3808, 10.1073/pnas.79.12.3808 · DOI
Cited by
Pathogenic tau–induced transposable element–derived dsRNA drives neuroinflammation
Ochoa, E., Ramirez, P., Gonzalez, E., De Mange, J., Ray, W. J., Bieniek, K. F., & Frost, B. (2023) · Science Advances · doi:10.1126/sciadv.abq5423 · Cited by 73
Repetitive elements in aging and neurodegeneration
Copley, K. E., & Shorter, J. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.008 · Cited by 70
“ExcessTEsmayactivatein fl ammationpathwaysvia increasedcytosolicDNAordsRNAelicitinganinterferonresponse[31,71,85,93 – 97, 107 , 109, Satellite DNA alterations also have far-reaching cellular consequences.”
BackgroundResultInfluential
Metadata
- Authors
- Heinrich, M. J., Purcell, C. A., Pruijssers, A. J., Zhao, Y., Spurlock, C. F., Sriram, S., Ogden, K. M., Dermody, T. S., Scholz, M. B., Crooke, P. S., Karijolich, J., & Aune, T. M.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 100
- Pages
- 40-51
- ISSN
- 0896-8411
- PMC
- PMC6513682
- Cited by
- 41
- References
- 6
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 342 d)
- Funders
- National Institutes of Health (R01AI038296, R01AI044924, R21AI128281, R21AI144193, R44AI124766)
- Vanderbilt University Medical Center
- Københavns Universitet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis. https://app.cochat.ai/papers/10.1016/j.jaut.2019.02.003
- The paper
- Heinrich, M. J., Purcell, C. A., Pruijssers, A. J., Zhao, Y., Spurlock, C. F., Sriram, S., Ogden, K. M., Dermody, T. S., Scholz, M. B., Crooke, P. S., Karijolich, J., & Aune, T. M. (2019). Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis. Journal of Autoimmunity. https://doi.org/10.1016/j.jaut.2019.02.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.